Aspire Biopharma Holdings, Inc. (ASBP) vs PMGC Holdings Inc. (ELAB)
A side-by-side comparison of Aspire Biopharma Holdings, Inc. and PMGC Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ASBP
Aspire Biopharma Holdings, Inc.
$8.88HealthcareDelayed quote: Oct 6, 2026, 11:53 AM EDT
ELAB
PMGC Holdings Inc.
$3.24HealthcareDelayed quote: Oct 6, 2026, 11:51 AM EDT
Total return — ASBP vs ELAB
growth of $100 · dividends reinvested · last 3yASBP -99.9% (-91.2%/yr)ELAB -100.0% (-99.4%/yr)ASBP compounded faster over this window
Log scale — wide-divergence pair
ASBP ELAB
ASBP vs ELAB: by the numbers
- •ELAB is the larger company ($1M vs $1M market cap).
- •Both run net losses; ELAB's is the smaller (-522.97% vs -11314.24% net margin).
Metrics side by side
Valuation
| Metric | ASBP | ELAB |
|---|---|---|
| P/S ratio | 10.49 | 0.57 |
| P/B ratio | 0.09 | 0.09 |
Profitability
| Metric | ASBP | ELAB |
|---|---|---|
| Gross margin | -1.87% | 10.31% |
| Operating margin | -312016.95% | -1250.11% |
| Net margin | -11314.24% | -522.97% |
| ROE | -93.97% | -80.57% |
| ROIC | -59.81% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.